Michael M. Pham
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients (NCT04837131) | Michael M. Pham | 2021-04-28 |
Track Michael M. Pham automatically
Every clearance here is in the API, with alerts when new ones post.